Cabergoline IP(0.5mg)
May 01, 2023
Cabergoline IP(0.5mg)
Caberglow is a medication that belongs to a class of drugs called dopamine receptor agonists. Caberglow works by stimulating the dopamine receptors in the brain, which helps to reduce the levels of prolactin hormone in the body.
Caberglow is a specific formulation of cabergoline that contains 0.5 milligrams of the active ingredient. Caberglow is commonly used to treat medical conditions such as hyperprolactinemia (a condition where there is an excessive amount of prolactin hormone in the blood), which can lead to various symptoms such as irregular menstrual periods, breast milk production in non-pregnant women, decreased sex drive, and infertility.
Caberglow is a prescription medication and should only be used under the supervision of a licensed healthcare provider. It is important to follow the dosing instructions provided by your doctor and to report any side effects or concerns you may have while taking Caberglow medication.
For further information please contact:
contact@sterispharma.com
Recent Post

SOLIFENAC 10: Effective Relief for Overactive Bladder.

PIDOMIDE 400: Strengthening Immunity with Pidotimod 400mg Tablet.

LYMECYCLE 408: A Reliable Antibiotic for Bacterial Infections.

LONICAZOLE PLUS 20: An Advanced Topical Solution for Skin Conditions.

APIXAZEN 2.5mg: A Reliable Anticoagulant for Blood Clot Prevention

PRAZIQUNA PLUS 600mg: An Effective Solution for Parasitic Infections.

Paracetamol IP 500 mg, Phenylephrine Hydrochloride IP 5 mg, Caffeine IP 30 mg, Diphenhydramine Hydrochloride IP 25 mg

Empagliflozin and Metformin Hydrochloride Prolonged Release 5 mg/500 mg Tablet.

Metformin Hydrochloride Extended Release 1000 mg Tablets: Gliempaflozin Tablet.

empagliflozin 25mg+ metformin hydrochloride (extended release) 1000 mg